Williams v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided October 28, 2022·No. 13-471·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 13-471V Filed: September 27, 2022

************************* WENDY WILLIAMS, * UNPUBLISHED * Petitioner, * v. * Decision on Interim Attorneys’ Fees and * Costs. SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * *************************

Richard Gage, Richard Gage, P.C., Cheyenne, WY, for petitioner. Althea Davis, United States Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEY’S FEES AND COSTS1

Roth, Special Master:

On July 12, 2013, Wendy Williams (“Ms. Williams” or “petitioner”) filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10, et seq.2 (the “Vaccine Act” or “Program”). Petitioner alleged that she developed multiple sclerosis (“MS”) and optic neuritis after receiving a Hepatitis B vaccination on February 16, 2011. See Petition (“Pet.”), ECF No. 1. On December 7, 2021, petitioner’s counsel, Mr. Gage, filed a Motion for Interim Attorneys’ Fees and Costs pursuant to Section 15(e) of the Vaccine Act. After careful consideration, the undersigned has determined to grant in part the request for the reasons set forth below.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (1986). Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). I. Procedural History

This case was filed on July 12, 2013 and was initially assigned to Special Master Dorsey. ECF No. 1, 3. Medical records in the form of a compact disc were received by the Clerk’s Office on July 26, 2013. An initial status conference was held on September 5, 2013, after which petitioner was ordered to file all outstanding medical records and a statement of completion. ECF No. 10. Petitioner filed a status report on October 4, 2013, indicating that she had filed all records to date, apart from records from one facility that she was still trying to obtain. ECF No. 12. On November 4, 2013, petitioner filed the remaining outstanding record and an amended statement of completion. ECF Nos. 14-15, Pet. Ex. 14.

Respondent filed his Rule 4 (c) Report on February 7, 2014, indicating the case was not appropriate for compensation. ECF No. 19. Another status conference was held on April 3, 2014, following which petitioner was ordered to file outstanding medical records and an expert report. ECF No. 21. Petitioner filed additional medical records on April 30, 2014, ECF No. 22, Pet. Ex. 15, and on June 4, 2014, ECF No. 26, Pet. Ex. 16-17, and filed an expert report on August 15, 2014. ECF No. 31, Pet. Ex. 18-19. Petitioner filed a supplemental expert report on May 13, 2015. ECF No. 48, Pet. Ex. 22. On July 27, 2015, respondent filed an expert report. ECF No. 53, Resp. Ex. Q. The parties filed a joint status report on September 14, 2015, respondent maintaining his position the case was not appropriate for compensation. ECF No. 55.

This case was reassigned to me on October 22, 2015. Notice of Reassignment, ECF No. 56-57. A status conference was held on November 13, 2015, where the parties were instructed to file a joint status report on the possibility of settlement. ECF No. 58. The parties filed a joint status report on December 14, 2015, indicating that respondent was “willing to entertain a demand.” ECF No. 59. Over the next year, the parties engaged in settlement discussions in an attempt to informally resolve this matter. Another status conference was held on April 19, 2017, where petitioner was ordered to file a status report in 30 days advising on the progress of settlement discussions. ECF No. 73. Further settlement discussions ensued over the next several months. Petitioner filed a status report on September 4, 2018, stating that she needed more time to contemplate the proposed settlement offer. ECF No. 93. The parties continued to engage in settlement discussions through October 2018.

On October 19, 2018, petitioner’s then counsel moved for Interim Attorneys’ Fees and Costs. ECF No. 95. On October 22, 2018, attorney Richard Gage was substituted as petitioner’s representation. ECF No. 96. Apparently, a tentative settlement agreement had been reached but, upon further consideration, was rejected on November 19, 2018. ECF No. 98. On January 15, 2019, the undersigned awarded attorneys’ fees and costs to petitioner’s prior counsel. No. 101.

The case was referred to ADR on January 29, 2019. ECF No. 106. During the course of ADR, petitioner was ordered to provide additional documentation in support of her damage claim. The case was removed from ADR on January 2, 2020, following petitioner’s status report stating that mediation would likely be unsuccessful in this case. ECF No. 110-111. Throughout the next year, both parties filed medical literature and additional expert reports, and petitioner filed updated medical records. A one-day hearing was held via video conference on February 18, 2021.

2 Respondent filed a post-hearing brief on August 20, 2021. ECF No. 166. Petitioner filed her post- hearing brief on August 23, 2021. ECF No. 167.

On December 7, 2021, petitioner filed a Motion for Interim Attorneys’ Fees and Costs (“Motion for Fees”) requesting a total of $113,549.163, representing $64,107.70 in attorneys’ fees and $50,872.46 in attorneys’ costs. Motion for Fees, ECF No. 168. Respondent filed his response on December 27, 2021, stating no objection and submitting that all the statutory requirements have been met. ECF No. 169.

This matter is now ripe for decision.

II. Legal Framework

The Vaccine Act permits an award of reasonable attorneys’ fees and other costs. § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, petitioner’s counsel is automatically entitled to reasonable attorneys’ fees. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008).

Free access — add to your briefcase to read the full text and ask questions with AI

Williams v. Secretary of Health and Human Services, (uscfc 2022).

Williams v. Secretary of Health and Human Services (Williams v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related